2021
DOI: 10.1002/pon.5668
|View full text |Cite
|
Sign up to set email alerts
|

Resilience patterns and transitions in the Be Resilient To Breast Cancer trial: an exploratory latent profile transition analysis

Abstract: Objective Be Resilient to Breast Cancer (BRBC), a theoretically‐derived, resilience‐based, culturally‐tailored, supportive‐expressive group therapy (SEGT), has been developed to help promote patients' resilience in breast cancer. Data from patients receiving BRBC intervention was utilized to explore and define characteristics of resilience patterns and their transitions over time. Methods Resilience was used as a primary outcome and 391 patients completed Resilience Scale Specific to Cancer at enrollment (T0),… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 39 publications
(59 reference statements)
1
19
0
Order By: Relevance
“…Participants and data collection Participants were recruited from our Be Resilient to Cancer Program (BRCP) between July 2016 and November 2017 and was approved by the Human Research Ethics Committee (No.2016KYTD08) [13][14][17][18]. The inclusion criteria were: (1) Family caregivers (FCs), (2) their relatives had a con rmed diagnosis of cancer, (3) aged > 18 years, (4) could communicate in Mandarin or Cantonese uently.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Participants and data collection Participants were recruited from our Be Resilient to Cancer Program (BRCP) between July 2016 and November 2017 and was approved by the Human Research Ethics Committee (No.2016KYTD08) [13][14][17][18]. The inclusion criteria were: (1) Family caregivers (FCs), (2) their relatives had a con rmed diagnosis of cancer, (3) aged > 18 years, (4) could communicate in Mandarin or Cantonese uently.…”
Section: Methodsmentioning
confidence: 99%
“…Recently, we developed a new Resilience Scale Speci c to Cancer (RS-SC) based on Shift-Persist theory and Resilience Model to Breast Cancer [9][10]. Then, a 10-item version (RS-SC-10) with high item functions was developed based on Item Response Theory (IRT) analysis [11][12], and validated in our Be Resilient to Breast Cancer (BRBC) program [13][14]. Thus, we have interests whether this powerful resilience instrument can also be applied to FCs, which will provide important information for resilience screening in clinical practice.…”
Section: Introductionmentioning
confidence: 99%
“…), describing resilience and its associations with other aspects of the psychological, social, and physical well-being of patients with chronic disease. Our specific aim was first, to recognize distinct resilience trajectories during diagnosis, treatment, and survivorship throughout the course of chronic disease, which was not achieved in the current collection (6,7). Second, articles about resilience theory and instrument development are limited, and more future research should be undertaken to develop new resilience theories and instruments for the cultural and developmental levels of measuring the psychological and social aspects of resilience, which can help address debates about resilience construction (8)(9)(10).…”
Section: Resilience In Chronic Diseasementioning
confidence: 99%
“…Participants were recruited from our Be Resilient to Cancer Program (BRCP) between July 2016 and November 2017 and was approved by the Human Research Ethics Committee (No.2016KYTD08) [13,14,17,18]. The inclusion criteria were: (1) Family caregivers (FCs), (2) their relatives had a confirmed diagnosis of cancer, (3) aged > 18 years, (4) could communicate in Mandarin or Cantonese fluently.…”
Section: Participants and Data Collectionmentioning
confidence: 99%
“…Recently, we developed a new Resilience Scale Specific to Cancer (RS-SC) based on Shift-Persist theory and Resilience Model to Breast Cancer [9,10]. Then, a 10-item version (RS-SC-10) with high item functions was developed based on Item Response Theory (IRT) analysis [11,12], and validated in our Be Resilient to Breast Cancer (BRBC) program [13,14]. Thus, we have interests whether this powerful resilience instrument can also be applied to FCs, which will provide important information for resilience screening in clinical practice.…”
Section: Introductionmentioning
confidence: 99%